Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Current Deferred Revenue (2016 - 2020)

InspireMD filings provide 11 years of Current Deferred Revenue readings, the most recent being $19000.0 for Q3 2020.

  • On a quarterly basis, Current Deferred Revenue changed 0.0% to $19000.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $19000.0, a 0.0% change, with the full-year FY2019 number at $20000.0, down 20.0% from a year prior.
  • Current Deferred Revenue hit $19000.0 in Q3 2020 for InspireMD, up from $17000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $111000.0 in Q2 2016 to a low of $17000.0 in Q1 2020.
  • Median Current Deferred Revenue over the past 5 years was $25000.0 (2018), compared with a mean of $30222.2.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 80.24% in 2016 and later increased 25.0% in 2018.
  • InspireMD's Current Deferred Revenue stood at $33000.0 in 2016, then plummeted by 39.39% to $20000.0 in 2017, then increased by 25.0% to $25000.0 in 2018, then decreased by 20.0% to $20000.0 in 2019, then decreased by 5.0% to $19000.0 in 2020.
  • The last three reported values for Current Deferred Revenue were $19000.0 (Q3 2020), $17000.0 (Q2 2020), and $17000.0 (Q1 2020) per Business Quant data.